Skip to main content

Table 1 Cancer group characteristics (n = 84)

From: Impact of cancer occurrence on health-related quality of life: A longitudinal pre-post assessment

  n proportion mean sd a
Site     
   Breast 18 21.4   
   Cutaneous 26 30.9   
   Colo-rectal 11 13.1   
   Gynaecological 2 2.4   
   Hematologic 3 3.6   
   Prostate 12 14.3   
   Lung 1 1.2   
   Thyroid 8 9.5   
   Bladder 2 2.4   
   Other 1 1.2   
Stage at diagnosis of solid cancer     
   0 (in situ) 6 7.4   
   I 43 55.6   
   II 28 32.1   
   III 3 3.7   
   Unknown 1 1.2   
Time between diagnosis and T2 QoL assessment (months)    15.2 7.9
Treatment before T2 QoL assessment     
   Surgery 74 88.1   
   Time between treatment and T2 (months)    15.6 7.7
   Radiotherapy 18 21.4   
   Time between treatment and T2 (months)    13.9 8.4
   Chemotherapy 9 10.7   
   Time between treatment and T2 (months)    10.6 6.6
   No treatment 7 8.3   
  1. a standard deviation